Form 8-K - Current report:
SEC Accession No. 0001640334-24-000013
Filing Date
2024-01-05
Accepted
2024-01-05 16:15:19
Documents
16
Period of Report
2024-01-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmmj_8k.htm   iXBRL 8-K 26543
2 NEWS RELEASE bmmj_ex991.htm EX-99.1 10938
8 bmmj_ex991img2.jpg GRAPHIC 3802
  Complete submission text file 0001640334-24-000013.txt   161409

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmmj-20240105.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmmj-20240105_lab.xml EX-101.LAB 13114
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmmj-20240105_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmmj-20240105_pre.xml EX-101.PRE 8222
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmmj-20240105_def.xml EX-101.DEF 2099
10 EXTRACTED XBRL INSTANCE DOCUMENT bmmj_8k_htm.xml XML 3273
Mailing Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6
Business Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6 604-376-3567
BODY & MIND INC. (Filer) CIK: 0001715611 (see all company filings)

EIN.: 981319227 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55940 | Film No.: 24516421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)